Valuation: Abbott Laboratories

Market Cap 17TCr 15TCr 13TCr 12TCr 24TCr 15,82200Cr 24TCr 1,60300Cr 62TCr 7,77700Cr 62TCr 61TCr 26,80000Cr P/E 2026 *
23.6x
P/E 2027 * 20.1x
Enterprise Value 18TCr 16TCr 14TCr 13TCr 25TCr 16,93500Cr 26TCr 1,71500Cr 67TCr 8,32400Cr 67TCr 65TCr 28,68500Cr EV / Sales 2026 *
3.54x
EV / Sales 2027 * 3.2x
Free-Float
86.73%
Yield 2026 *
2.67%
Yield 2027 * 2.85%
1 day+3.49%
1 week+1.36%
Current month+5.14%
1 month+9.67%
3 months-7.26%
6 months-23.18%
Current year-23.86%
1 week 90.61
Extreme 90.61
95.74
1 month 87.07
Extreme 87.0706
95.74
Current year 81.97
Extreme 81.97
129.46
1 year 81.97
Extreme 81.97
137.49
3 years 81.97
Extreme 81.97
141.23
5 years 81.97
Extreme 81.97
142.6
10 years 37.38
Extreme 37.38
142.6
Manager TitleAgeSince
Chief Executive Officer 52 31/03/2020
Director of Finance/CFO 53 01/09/2023
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 09/12/2011
Director/Board Member 67 09/12/2011
Director/Board Member 71 16/02/2017
Date Insider Type Main position Quantity % Market Cap.
30/06Free

Director

416 0.0000%
30/06Free

Director

347 0.0000%
30/06Free

Director

432 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
+3.49%+1.36%-29.04%-11.02% 17TCr
+5.04%+2.73%-5.88%-4.53% 11TCr
+2.80%+3.63%+0.09%+55.31% 5.77TCr
+1.33%+1.39%+53.16%+49.84% 5.32TCr
+3.39%+1.39%-10.26%-39.65% 4.36TCr
+3.50%+11.11% - - 3.65TCr
+3.47%+1.58%-14.08%-43.91% 2.75TCr
+0.20%+4.24%+64.56%-3.33% 2.58TCr
+2.78%+1.17%-8.15%-0.43% 2.13TCr
-1.04%+2.85%-11.67%-21.21% 2.03TCr
Average +2.50%+4.15%+4.30%-2.10% 5.59TCr
Weighted average by Cap. +3.16%+3.44%-4.20%+0.13%

Financials

2026 *2027 *
Net sales 5.03TCr 4.39TCr 4.04TCr 3.76TCr 7.14TCr 4,78500Cr 7.25TCr 48TCr 19TCr 2,35200Cr 19TCr 18TCr 8,10500Cr 5.47TCr 4.79TCr 4.4TCr 4.1TCr 7.78TCr 5,21300Cr 7.89TCr 53TCr 21TCr 2,56200Cr 21TCr 20TCr 8,83000Cr
Net income 701.79Cr 613.51Cr 563.81Cr 525.54Cr 996.8Cr 67TCr 1.01TCr 6.77TCr 2.63TCr 33TCr 2.63TCr 2.58TCr 1,13200Cr 838.93Cr 733.4Cr 673.99Cr 628.24Cr 1.19TCr 80TCr 1.21TCr 8.09TCr 3.15TCr 39TCr 3.15TCr 3.08TCr 1,35300Cr
Net Debt 1.17TCr 1.02TCr 939.08Cr 875.32Cr 1.66TCr 1,11300Cr 1.69TCr 11TCr 4.38TCr 55TCr 4.39TCr 4.29TCr 1,88500Cr 885.69Cr 774.27Cr 711.55Cr 663.25Cr 1.26TCr 84TCr 1.28TCr 8.54TCr 3.32TCr 41TCr 3.32TCr 3.25TCr 1,42800Cr
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
1,15,000
Date Price Change Volume
02/26/02 $95.40 +3.49% 1,06,44,582
01/26/01 $92.18 +1.59% 1,39,35,849
30/26/30 $90.74 -2.12% 1,00,21,142
29/26/29 $92.71 -1.50% 1,03,14,404
26/26/26 $94.12 +0.94% 1,64,65,117
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
95.40USD
Average target price
116.72USD
Spread / Average Target
+22.35%

Quarterly revenue - Rate of surprise